RedHill Biopharma Ltd.
Underestimation
Efficiency
Debt
Dividends
Growth impulse
IP Score
4.12/10
Yield per half year: -23.65%
Sector: Healthcare
More functionality and data for company and portfolio analysis is available by subscription